Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review

Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān

Shahrzad Mohseni¹  Fatemeh Bandarian²  Ozra Tabatabaei Malazy³  Bagher Larijani⁴ 

[1] Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran;Metabolomics and Genomics Research Center Endocrinology and Metabolism Molecular- Cellular SciencesInstitute, Tehran University of Medical Sciences, Tehran, Iran;Non-Communicable Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran;Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran;

关键词: sulfonylurea compounds;    glibenclamide;    diabetes mellitus;    pharmacogenomics;    precision medicine;   

DOI  :  

来源: DOAJ

【 授权许可】

Unknown